BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 35762356)

  • 1. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
    Zhu H; Galdos FX; Lee D; Waliany S; Huang YV; Ryan J; Dang K; Neal JW; Wakelee HA; Reddy SA; Srinivas S; Lin LL; Witteles RM; Maecker HT; Davis MM; Nguyen PK; Wu SM
    Circulation; 2022 Jul; 146(4):316-335. PubMed ID: 35762356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
    Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
    Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment.
    Kim H; Park S; Han KY; Lee N; Kim H; Jung HA; Sun JM; Ahn JS; Ahn MJ; Lee SH; Park WY
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36787939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells specific for α-myosin drive immunotherapy-related myocarditis.
    Axelrod ML; Meijers WC; Screever EM; Qin J; Carroll MG; Sun X; Tannous E; Zhang Y; Sugiura A; Taylor BC; Hanna A; Zhang S; Amancherla K; Tai W; Wright JJ; Wei SC; Opalenik SR; Toren AL; Rathmell JC; Ferrell PB; Phillips EJ; Mallal S; Johnson DB; Allison JP; Moslehi JJ; Balko JM
    Nature; 2022 Nov; 611(7937):818-826. PubMed ID: 36385524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor-related myocarditis.
    Lou B; Guo M; Zheng T; Liu J; Wang C; Chen T; Chen F; Fan X; Gao S; Liang X; Qiang H; Li L; Zhou B; Yuan Z; She J
    Immunology; 2024 Jun; 172(2):235-251. PubMed ID: 38425094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
    Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
    bioRxiv; 2023 Apr; ():. PubMed ID: 37162929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
    Franken A; Van Mol P; Vanmassenhove S; Donders E; Schepers R; Van Brussel T; Dooms C; Yserbyt J; De Crem N; Testelmans D; De Wever W; Nackaerts K; Vansteenkiste J; Vos R; Humblet-Baron S; Lambrechts D; Wauters E
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
    Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
    Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.
    Won T; Kalinoski HM; Wood MK; Hughes DM; Jaime CM; Delgado P; Talor MV; Lasrado N; Reddy J; Čiháková D
    Cell Rep; 2022 Nov; 41(6):111611. PubMed ID: 36351411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral immune mapping and multi-omics analysis in Pd-1 inhibitor-induced myocarditis.
    Gao J; Wang Y; Lu L; Ma M; Ling J; Sun L; Chen Y; Liu F; Yu Y; Liu T; Wu D
    J Leukoc Biol; 2023 Jul; 114(2):164-179. PubMed ID: 37202883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonally expanded CD38
    Wang R; Singaraju A; Marks KE; Shakib L; Dunlap G; Adejoorin I; Greisen SR; Chen L; Tirpack AK; Aude C; Fein MR; Todd DJ; MacFarlane L; Goodman SM; DiCarlo EF; Massarotti EM; Sparks JA; Jonsson AH; Brenner MB; Postow MA; Chan KK; Bass AR; Donlin LT; Rao DA
    Sci Immunol; 2023 Jul; 8(85):eadd1591. PubMed ID: 37506196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.
    Bruns H; Meinken C; Schauenberg P; Härter G; Kern P; Modlin RL; Antoni C; Stenger S
    J Clin Invest; 2009 May; 119(5):1167-77. PubMed ID: 19381021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonally expanded, thyrotoxic effector CD8
    Lechner MG; Zhou Z; Hoang AT; Huang N; Ortega J; Scott LN; Chen HC; Patel AY; Yakhshi-Tafti R; Kim K; Hugo W; Famini P; Drakaki A; Ribas A; Angell TE; Su MA
    Sci Transl Med; 2023 May; 15(696):eadg0675. PubMed ID: 37196065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-Gamma-Producing CD8
    Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
    Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity.
    Huang YV; Waliany S; Lee D; Galdos FX; Witteles RM; Neal JW; Fan AC; Maecker HT; Nguyen PK; Wu SM; Zhu H
    JACC CardioOncol; 2022 Dec; 4(5):629-634. PubMed ID: 36636436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
    Coustal C; Vanoverschelde J; Quantin X; Lesage C; Michot JM; Lappara A; Ederhy S; Assenat E; Faure M; Issa N; Lambotte O; Puyade M; Dereure O; Tosi D; Rullier P; Serre I; Larcher R; Klouche K; Chanques G; Vernhet-Kovacsik H; Faillie JL; Agullo A; Roubille F; Guilpain P; Maria ATJ
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune Checkpoint Inhibitor Heart: How CD45RA
    Kallikourdis M; Condorelli G
    Circulation; 2022 Jul; 146(4):336-338. PubMed ID: 35877835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.